From July 30th to August 1st, local time, the 76th Annual Meeting of the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) was held at the McCormick Place Convention Center in Chicago, USA. It is the world's largest international in vitro diagnostic academic organization. ADLM's annual meeting and clinical laboratory exhibition (Clinical Lab Expo) has been held since 1950 and has become one of the most important international academic conferences in the field of clinical testing worldwide. It has an important international influence in this field. This exhibition attracted nearly 900 global companies and institutions from more than 100 countries around the world, and 18,000+ laboratory medicine professionals and healthcare leaders participated in witnessing and discussing new directions in the development of clinical testing.
VACURE made a strong appearance with multiple series of POCT fully automatic intelligent products and multi-scenario solutions, communicated with experts at the conference, and its innovative breakthroughs were actively recognized by industry experts.
At this event, VACURE expanded its presence in North America and showed its good style to overseas colleagues in the industry. The outstanding performance of the microfluidic fluorescent immunoassay DISKFLU platform joint inspection related star products and LYOFIA's new single inspection star products attracted many global experts and customers to stop and consult, and to exchange and discuss new technologies, new products and new trends.
The booth displayed tumor markers, three anemia items, myocardial markers, tumor markers, respiratory diseases, inflammatory markers, and infectious disease markers. In addition, star products such as rapid diagnosis of growth and development, rapid detection of diabetes, and raw materials of fluorescent immunomicrospheres were also displayed, which attracted the favor of the participants. The staff of the Microkang Bio team actively received and fully introduced the product advantages of Microkang Bio. Its timeliness, accuracy, and portability have aroused strong interest in cooperation among customers.
POCT product list
A. LYOFIA® microfluidic rapid diagnosis platform
LYOFIA-I - Simple POCT
- Single Channel
- Small size, Light weight
Simple and Fast
LYOFIA8 - Convenient POCT
- Small and Portable
- 8 Channels, 8 samples at a time
- 96 tests/hour
Small & Portable
DISKFLU - Efficient POCT
- Automatic
- Single Channel
- 15 minutes, accurately detect 9 parameters
- Centrifugation Microfluidics
Small but Smart
Part B Recommended TEST
INFERTILITY
AsAb EmAb ATAb AOA AZPA ACA AhcGA
GROWTH & DEVELOPMENT
Ferritin Folate VB12 25-OH VD GH IGFBP-3 IGF-I
Thyroid & Hormone
TT3 TT4 TSH FT3 FT4
AMH β-HCG FSH LH Prol E2 Tes Prog
PREMATURE & ECLAMPSIA
PLGF & sFLT-1 PAMG-1 fFN IGFBP-1
DIABETES
HbA1c C-peptide mAIb β2-MG
CARDIAC MARKER
NT-proBNP MYO D-dimer hs-cTnI CK-MB AMI-3 BNP sST2 MPO HCY
INFLAMMATION
CRP PCT SAA IL-6 CRP & SAA PCT & IL-6
GASTRIC FUNCTION
PG I & PG II G-17 FOB HP-Ag HP-Ab
TUMOR MARKER
FOB AFP PSA CEA VEGF ProGRP CYFRA21-1
INFECTIOUS DISEASE
Dengue-Ag Dengue-Ab RSAg-5 Flu & RSV TP-Ab
OTHERS
Total IgE Calprotectin
More are on the way...
With the expansion of North and South America, the business volume at home and abroad continues to increase. In order to understand the cutting-edge information and advanced technology of the life science industry, understand customer needs, and establish a deep cooperative relationship with customers, Micro-Bio actively participates in exhibitions around the world.
Next stop, Micro-Bio invites you to meet in Kenya, September 4-6, booth number: 1G.74, we will see you~
ABOUT VACURE
Precise and flexible, True Microfluidics
VACURE is a high-tech enterprise focusing on the field of in vitro diagnostics (IVD) point-of-care testing (POCT). The company has brought together many R&D personnel (accounting for 39%) from the Provincial Thousand Talents Program. Based on self-developed patented core technologies such as microfluidic chip design, time-resolved fluorescent nanomaterials, and inkjet freeze-drying, through a number of underlying technological innovations, it has independently developed the fluorescent immunoassay quantitative detection platform LYOFIA system, iteratively upgraded the DISKFLU disc-type microfluidic immunoassay chip system, and laid out the GENFLU microfluidic molecular integrated POCT detection system to create POCT immune and molecular products with excellent performance, and realize the self-development and production of the entire chain of raw materials, instruments and reagents. Since setting sail in 2023, the products have been exported to more than 70+ countries at home and abroad.
Thousands of blows are still strong. Under the torrent of the times, VACURE has climbed up the peak against the current. It has conducted extensive exchanges with overseas customers in many countries around the world, including the United States, the United Kingdom, the United Arab Emirates, Peru, Palestine, Germany, Australia, etc., established mutually beneficial and win-win connections, and laid a solid foundation for future cooperation. In the future, Microkon Bio will continue to uphold its mission and original intention of "Supporting the medical industry and protecting people's health". With the spirit of craftsmanship, VACURE will continue to provide high-quality products and services to contribute to the medical industry, live up to the trust of customers, and win the future down to earth!